Abstract

Thrombomodulin (TM) is highly expressed in endothelial cells and plays the key role in maintaining physical homeostasis. In addition, many pieces of evidence also show that TM contains the diagnostic value for malignant diseases. TM has been found to correlate with metastatic status in multiple cancers, but its role in prostate cancer progression remains unclear. TM expression was determined in prostate cancer cells (DU-145 and PC-3 cells) using real-time PCR and Western blotting. TM expression was manipulated in prostate cancer cells using TM-specific shRNA and an overexpression system. The proliferation, adhesion, and migratory ability of prostate cancer cells expressing various TM levels were determined using the x'Celligence biosensor system and a transwell migration assay. Higher levels of TM transcription and translation were found in DU-145 cells and were negatively correlated with the low migratory ability of DU-145 cells. After silencing TM expression in DU-145 cells, cell growth decreased, but cell adhesion and migration dramatically increased. TM overexpression in PC-3 cells reduced their metastatic ability. We investigated the possible mechanisms of this phenomenon and determined that the enhanced cell migration was mediated through the expression of E-cadherin and vimentin. TM may be a modulator of hormone-independent prostate cancer (HIPC) metastasis. The downregulation of TM expression enhanced the migratory ability of these cells via an increase in vimentin expression and a decrease in E-cadherin expression.

Original languageEnglish
Pages (from-to)6047-6054
Number of pages8
JournalTumor Biology
Volume35
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

Thrombomodulin
Epithelial-Mesenchymal Transition
Prostatic Neoplasms
Biomarkers
Hormones
Vimentin
Cadherins
Cell Movement
Biosensing Techniques
Cell Adhesion
Small Interfering RNA
Real-Time Polymerase Chain Reaction
Homeostasis
Down-Regulation

Keywords

  • Epithelial-to-mesenchymal transition (EMT)
  • Migration
  • Prostate cancer
  • Thrombomodulin (TM)

ASJC Scopus subject areas

  • Cancer Research

Cite this

@article{f7f4d8ac8b3844258e948b1e346371c5,
title = "Thrombomodulin mediates the migratory ability of hormone-independent prostate cancer cells through the regulation of epithelial-to-mesenchymal transition biomarkers",
abstract = "Thrombomodulin (TM) is highly expressed in endothelial cells and plays the key role in maintaining physical homeostasis. In addition, many pieces of evidence also show that TM contains the diagnostic value for malignant diseases. TM has been found to correlate with metastatic status in multiple cancers, but its role in prostate cancer progression remains unclear. TM expression was determined in prostate cancer cells (DU-145 and PC-3 cells) using real-time PCR and Western blotting. TM expression was manipulated in prostate cancer cells using TM-specific shRNA and an overexpression system. The proliferation, adhesion, and migratory ability of prostate cancer cells expressing various TM levels were determined using the x'Celligence biosensor system and a transwell migration assay. Higher levels of TM transcription and translation were found in DU-145 cells and were negatively correlated with the low migratory ability of DU-145 cells. After silencing TM expression in DU-145 cells, cell growth decreased, but cell adhesion and migration dramatically increased. TM overexpression in PC-3 cells reduced their metastatic ability. We investigated the possible mechanisms of this phenomenon and determined that the enhanced cell migration was mediated through the expression of E-cadherin and vimentin. TM may be a modulator of hormone-independent prostate cancer (HIPC) metastasis. The downregulation of TM expression enhanced the migratory ability of these cells via an increase in vimentin expression and a decrease in E-cadherin expression.",
keywords = "Epithelial-to-mesenchymal transition (EMT), Migration, Prostate cancer, Thrombomodulin (TM)",
author = "Wu, {Chun Te} and Chang, {Yu Jia} and Chen, {Miao Fen} and Liu, {Jun Jen} and Wei, {Po Li} and Weu Wang and Liu, {Hui Hsiung}",
year = "2014",
doi = "10.1007/s13277-014-1801-8",
language = "English",
volume = "35",
pages = "6047--6054",
journal = "Tumor Biology",
issn = "1010-4283",
publisher = "Springer Netherlands",
number = "6",

}

TY - JOUR

T1 - Thrombomodulin mediates the migratory ability of hormone-independent prostate cancer cells through the regulation of epithelial-to-mesenchymal transition biomarkers

AU - Wu, Chun Te

AU - Chang, Yu Jia

AU - Chen, Miao Fen

AU - Liu, Jun Jen

AU - Wei, Po Li

AU - Wang, Weu

AU - Liu, Hui Hsiung

PY - 2014

Y1 - 2014

N2 - Thrombomodulin (TM) is highly expressed in endothelial cells and plays the key role in maintaining physical homeostasis. In addition, many pieces of evidence also show that TM contains the diagnostic value for malignant diseases. TM has been found to correlate with metastatic status in multiple cancers, but its role in prostate cancer progression remains unclear. TM expression was determined in prostate cancer cells (DU-145 and PC-3 cells) using real-time PCR and Western blotting. TM expression was manipulated in prostate cancer cells using TM-specific shRNA and an overexpression system. The proliferation, adhesion, and migratory ability of prostate cancer cells expressing various TM levels were determined using the x'Celligence biosensor system and a transwell migration assay. Higher levels of TM transcription and translation were found in DU-145 cells and were negatively correlated with the low migratory ability of DU-145 cells. After silencing TM expression in DU-145 cells, cell growth decreased, but cell adhesion and migration dramatically increased. TM overexpression in PC-3 cells reduced their metastatic ability. We investigated the possible mechanisms of this phenomenon and determined that the enhanced cell migration was mediated through the expression of E-cadherin and vimentin. TM may be a modulator of hormone-independent prostate cancer (HIPC) metastasis. The downregulation of TM expression enhanced the migratory ability of these cells via an increase in vimentin expression and a decrease in E-cadherin expression.

AB - Thrombomodulin (TM) is highly expressed in endothelial cells and plays the key role in maintaining physical homeostasis. In addition, many pieces of evidence also show that TM contains the diagnostic value for malignant diseases. TM has been found to correlate with metastatic status in multiple cancers, but its role in prostate cancer progression remains unclear. TM expression was determined in prostate cancer cells (DU-145 and PC-3 cells) using real-time PCR and Western blotting. TM expression was manipulated in prostate cancer cells using TM-specific shRNA and an overexpression system. The proliferation, adhesion, and migratory ability of prostate cancer cells expressing various TM levels were determined using the x'Celligence biosensor system and a transwell migration assay. Higher levels of TM transcription and translation were found in DU-145 cells and were negatively correlated with the low migratory ability of DU-145 cells. After silencing TM expression in DU-145 cells, cell growth decreased, but cell adhesion and migration dramatically increased. TM overexpression in PC-3 cells reduced their metastatic ability. We investigated the possible mechanisms of this phenomenon and determined that the enhanced cell migration was mediated through the expression of E-cadherin and vimentin. TM may be a modulator of hormone-independent prostate cancer (HIPC) metastasis. The downregulation of TM expression enhanced the migratory ability of these cells via an increase in vimentin expression and a decrease in E-cadherin expression.

KW - Epithelial-to-mesenchymal transition (EMT)

KW - Migration

KW - Prostate cancer

KW - Thrombomodulin (TM)

UR - http://www.scopus.com/inward/record.url?scp=84904734788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904734788&partnerID=8YFLogxK

U2 - 10.1007/s13277-014-1801-8

DO - 10.1007/s13277-014-1801-8

M3 - Article

C2 - 24633886

AN - SCOPUS:84904734788

VL - 35

SP - 6047

EP - 6054

JO - Tumor Biology

JF - Tumor Biology

SN - 1010-4283

IS - 6

ER -